Sodium glucose co‐transporter 2 inhibitors versus dipeptidyl peptidase‐4 inhibitors and the risk of ventricular arrhythmia among patients with type 2 diabetes: A population‐based cohort study
SGLT2i use was not associated with the risk of VA among patients with type 2 diabetes.
Authors
- Oriana Hoi Yun Yu (ORCID: https://orcid.org/0000-0003-4877-557X)
- Pascal Reynier (ORCID: https://orcid.org/0000-0003-0802-4608)
- Wang‐Choi Tang (ORCID: https://orcid.org/0000-0003-4520-6718)
- Kristian B. Filion (ORCID: https://orcid.org/0000-0001-6055-0088)
- Robert W. Platt (ORCID: https://orcid.org/0000-0002-5981-8443)
- Antonios Douros (ORCID: https://orcid.org/0000-0002-6005-4006)
Institutions
- Jewish General Hospital (CA)
- McGill University (CA)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-11-10
- DOI
- https://doi.org/10.1111/dom.70264
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- McGill University
- Deutsche Forschungsgemeinschaft
- Fonds de Recherche du Québec - Santé